Targeting prostate cancer cell lines with polo-like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitors
Michel D. Wissing, Janet Mendonca, Madeleine S.Q. Kortenhorst, Nadine S. Kaelber, Matthew Gonzalez, Eunice Kim, Hans Hammers, Paul J. Van Diest, Michael A. Carducci, Sushant K. Kachhap
Dive into the research topics of 'Targeting prostate cancer cell lines with polo-like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitors'. Together they form a unique fingerprint.